Madrigal Pharmaceuticals, Inc.
MDGL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001157601
In the last 90 days, Madrigal Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 3 sales; 414 institutions reported holding it in 13F filings for Q2 2026, worth $12.7B in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Madrigal Pharmaceuticals, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 283
- +30 vs. Q3 2024
- Shares held
- 23.0M
- +334.5K (+1.5%) vs. Q3 2024
- Total value
- $7.08B
- +$2.32B (+48.8%) vs. Q3 2024
- New holders
- 67
- 95 more added
- Sold out
- 37
- 77 more reduced
4 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MDGL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 414 | $12.7B |
| Q1 2026 | 380 | $12.4B |
| Q4 2025 | 387 | $13.7B |
| Q3 2025 | 352 | $10.7B |
| Q2 2025 | 305 | $7.13B |
| Q1 2025 | 321 | $7.85B |
| Q4 2024 | 283 | $7.08B |
| Q3 2024 | 257 | $4.77B |
| Q2 2024 | 257 | $6.41B |
| Q1 2024 | 266 | $5.64B |
| Q4 2023 | 226 | $4.57B |
| Q3 2023 | 206 | $2.54B |
| Q2 2023 | 208 | $3.43B |
| Q1 2023 | 223 | $3.36B |
| Q4 2022 | 189 | $3.86B |
| Q3 2022 | 135 | $763.2M |
| Q2 2022 | 138 | $857.7M |
| Q1 2022 | 140 | $1.20B |
| Q4 2021 | 144 | $1.01B |
| Q3 2021 | 133 | $876.5M |
| Q2 2021 | 151 | $1.09B |
| Q1 2021 | 137 | $1.43B |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Madrigal Pharmaceuticals, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Advantage Alpha Capital Partners LP | 0 | $0 | 0.00% | −1,643−100.0% | Sold out |
| Brown Advisory Inc | 0 | $0 | 0.00% | −1,625−100.0% | Sold out |
| Artia Global Partners LP | 0 | $0 | 0.00% | −1,557−100.0% | Sold out |
| Engineers Gate Manager LP | 0 | $0 | 0.00% | −1,501−100.0% | Sold out |
| Nomura Holdings Inc | 0 | $0 | 0.00% | −1,394−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −1,179−100.0% | Sold out |
| Assenagon Asset Management S.A. | 0 | $0 | 0.00% | −969−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −661−100.0% | Sold out |
| Quest Partners LLC | 0 | $0 | 0.00% | −581−100.0% | Sold out |
| Danske Bank A/S | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −50−100.0% | Sold out |
| NBC Securities, Inc. | 0 | $0 | 0.00% | −48−100.0% | Sold out |
| J.Safra Asset Management Corp | 0 | $0 | 0.00% | −44−100.0% | Sold out |
| Ashton Thomas Securities, LLC | 0 | $0 | 0.00% | −28−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| Wolff Wiese Magana LLC | 0 | $0 | 0.00% | −12−100.0% | Sold out |
| Ronald Blue Trust, Inc. | 0 | $0 | 0.00% | −7−100.0% | Sold out |
| Rakuten Securities, Inc. | 0 | $0 | 0.00% | −5−100.0% | Sold out |
| Capital Performance Advisors LLP | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| CVA Family Office, LLC | 0 | $0 | 0.00% | −2−100.0% | Sold out |
| Eagle Asset Management Inc | – | – | – | – | Not filed |
| Raymond James & Associates | – | – | – | – | Not filed |
| Sweet Financial Partners, LLC | – | – | – | – | Not filed |
| PEAK6 Investments LLC | – | – | – | – | Not filed |